Literature DB >> 25469074

Population-based study of the epidemiology of herpes zoster in Korea.

You Jeong Kim1, Chang Nam Lee1, Chi-Yeon Lim2, Woo Seok Jeon3, Young Min Park3.   

Abstract

General epidemiological data regarding herpes zoster (HZ) are necessary for treatment and prevention of this disease. In addition, epidemiological data can play an important role in evaluating the efficacy and impact of vaccination. Though several epidemiological studies of HZ in Korea have been conducted, they usually depend on hospital-based data and may not be representative of HZ characteristics all over Korea. The purpose of this study was to evaluate the incidence and other epidemiological features of HZ in the general Korean population. We used population-based medical records from the Health Insurance Review & Assessment Service, which includes 50,908,646 medical insurance subscribers, to calculate the incidence of HZ. Also, we analyzed an age-stratified random sample of 1,375,842 individuals to study descriptive epidemiologic characteristics of HZ in Korea in 2011. We observed that the incidence of HZ was 10.4 per 1,000 person-years and was strongly correlated with age. Sex had a major influence on HZ incidence; overall, there were 12.6 cases per 1,000 person years in women and 8.3 cases per 1,000 person years in men. There was no difference in incidence according to the locality and season.

Entities:  

Keywords:  Epidemiology; Herpes zoster; Korea; Population-Based Study

Mesh:

Year:  2014        PMID: 25469074      PMCID: PMC4248595          DOI: 10.3346/jkms.2014.29.12.1706

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  10 in total

Review 1.  The global epidemiology of herpes zoster.

Authors:  Barbara P Yawn; Don Gilden
Journal:  Neurology       Date:  2013-09-03       Impact factor: 9.910

2.  The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008.

Authors:  D Y Chao; Y Z Chien; Y P Yeh; P S Hsu; I B Lian
Journal:  Epidemiol Infect       Date:  2011-09-12       Impact factor: 2.451

3.  Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.

Authors:  Kenneth E Schmader; Myron J Levin; John W Gnann; Shelly A McNeil; Timo Vesikari; Robert F Betts; Susan Keay; Jon E Stek; Nickoya D Bundick; Shu-Chih Su; Yanli Zhao; Xiaoming Li; Ivan S F Chan; Paula W Annunziato; Janie Parrino
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

4.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

Review 5.  Herpes zoster and postherpetic neuralgia.

Authors:  Robert W Johnson
Journal:  Expert Rev Vaccines       Date:  2010-03       Impact factor: 5.217

Review 6.  Herpes zoster: a common disease that can have a devastating impact on patients' quality of life.

Authors:  Janet E McElhaney
Journal:  Expert Rev Vaccines       Date:  2010-03       Impact factor: 5.217

7.  Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.

Authors:  Leonardo Emberti Gialloreti; Monica Merito; Patrizio Pezzotti; Luigi Naldi; Antonio Gatti; Maud Beillat; Laurence Serradell; Rafaelle di Marzo; Antonio Volpi
Journal:  BMC Infect Dis       Date:  2010-08-03       Impact factor: 3.090

Review 8.  What does epidemiology tell us about risk factors for herpes zoster?

Authors:  Sara L Thomas; Andrew J Hall
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

9.  A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.

Authors:  Barbara P Yawn; Patricia Saddier; Peter C Wollan; Jennifer L St Sauver; Marge J Kurland; Lina S Sy
Journal:  Mayo Clin Proc       Date:  2007-11       Impact factor: 7.616

10.  Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom.

Authors:  A Gauthier; J Breuer; D Carrington; M Martin; V Rémy
Journal:  Epidemiol Infect       Date:  2008-05-09       Impact factor: 2.451

  10 in total
  25 in total

1.  A clinico-epidemiological study of herpes zoster.

Authors:  S K Aggarwal; S Radhakrishnan
Journal:  Med J Armed Forces India       Date:  2015-07-22

2.  Seasonality of herpes zoster and herpes zoster ophthalmicus.

Authors:  Elyse J Berlinberg; Eric Kim; Michael S Deiner; Casey Patterson; Travis C Porco; Nisha R Acharya
Journal:  J Clin Virol       Date:  2020-02-26       Impact factor: 3.168

3.  A systematic literature review of herpes zoster incidence worldwide.

Authors:  Désirée van Oorschot; Hilde Vroling; Eveline Bunge; John Diaz-Decaro; Desmond Curran; Barbara Yawn
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

4.  Disease Burden Due to Herpes Zoster among Population Aged ≥50 Years Old in China: A Community Based Retrospective Survey.

Authors:  Yan Li; Zhijie An; Dapeng Yin; Yanmin Liu; Zhuoying Huang; Jianfang Xu; Yujie Ma; Qiufeng Tu; Qi Li; Huaqing Wang
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

5.  Epidemiology of Postherpetic Neuralgia in Korea: An Electronic Population Health Insurance System Based Study.

Authors:  Myong-Joo Hong; Yeon-Dong Kim; Yong-Kwan Cheong; Seon-Jeong Park; Seung-Won Choi; Hyon-Joo Hong
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  A Study of Intravenous Administration of Vitamin C in the Treatment of Acute Herpetic Pain and Postherpetic Neuralgia.

Authors:  Min Sung Kim; Dong Jin Kim; Chan Ho Na; Bong Seok Shin
Journal:  Ann Dermatol       Date:  2016-11-23       Impact factor: 1.444

Review 7.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

8.  Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults.

Authors:  Won Suk Choi; Jung-Hyun Choi; Jun Yong Choi; Joong Sik Eom; Sang Il Kim; Hyunjoo Pai; Kyong Ran Peck; Jang Wook Sohn; Hee Jin Cheong
Journal:  J Korean Med Sci       Date:  2015-12-24       Impact factor: 2.153

9.  Validation of Herpes Zoster Diagnosis Code in the Electronic Medical Record: A Retrospective, Multicenter Study.

Authors:  Yoon Seob Kim; Hyun-Min Seo; Chul Hwan Bang; Ji Hyun Lee; Yong-Gyu Park; You Jeong Kim; Gyong Moon Kim; Chul Jong Park; Hyun Jeong Park; Dong Soo Yu; Jun Young Lee; Young Min Park
Journal:  Ann Dermatol       Date:  2018-02-21       Impact factor: 1.444

10.  Monitoring Interest in Herpes Zoster Vaccination: Analysis of Google Search Data.

Authors:  Elyse J Berlinberg; Michael S Deiner; Travis C Porco; Nisha R Acharya
Journal:  JMIR Public Health Surveill       Date:  2018-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.